Altimmune, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Altimmune, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2012 to Q3 2024.
  • Altimmune, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Altimmune, Inc. annual Income Tax Expense (Benefit) for 2022 was -$197K.
  • Altimmune, Inc. annual Income Tax Expense (Benefit) for 2020 was -$5.42M, a 9160% decline from 2019.
  • Altimmune, Inc. annual Income Tax Expense (Benefit) for 2019 was -$58.5K, a 99% increase from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $0 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q3 2023 $0 $0 +$197K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$197K $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$197K $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$197K $0 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$197K -$197K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$110K $0 +$482K Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-09
Q2 2021 -$592K $0 +$1.58M Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-10
Q1 2021 -$2.17M $0 +$3.25M Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-17
Q4 2020 -$5.42M -$110K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$482K -$424K -724% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$1.58M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$3.25M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2019 -$58.5K +$771K +92.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q4 2018 -$6.15M -$2.83M -$721K -34.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$5.43M -$829K +$703K +45.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$6.13M -$1.5M -$503K -50.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$5.63M -$992K +$9.68K +0.97% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$5.64M -$2.11M -$2.06M -4457% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$3.57M -$1.53M -$1.55M -10029% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$2.03M -$994K -$1.01M -6538% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$1.02M -$1M -$1.02M -6586% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $0 -$46.3K -$61.7K -400% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $61.7K $15.4K $0 0% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $61.7K $15.4K +$4.37K +39.5% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $57.4K $15.4K -$4.37K -22.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $61.7K $15.4K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 $15.4K -$9.63K -38.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $11.1K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $19.8K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2014 $25.1K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2013 $49.9K $11.2K -$4.93K -30.5% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $54.9K $9.74K -$141K -93.5% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $196K $6.92K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-11
Q3 2012 $22.1K Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $16.1K Mar 31, 2012 Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $150K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.